rch Stocks Content and data provided by v
Post# of 11899
| Snapshot: CBISCANNABIS SCIENCE INC 0.0735 |
| |
Cannabis Science, Inc., a development stage company, engages in the development, production, and commercialization of phytocannabinoid-based pharmaceutical products. ESG ratings enable you to leverage independent ESG research to evaluate how companies are managing ESG risks and addressing ESG opportunities. Log in for more information Full Time Employees: -- www.cannabisscience.com 6946 North Academy Boulevard, Suite B 254 1-888-889-0888 | Analyst OpinionsThe Equity Summary Score is an accuracy-weighted sentiment derived from the ratings of independent research providers on Fidelity.com. It uses the past relative accuracy of the providers in determining the emphasis placed on any individual opinion. Learn More.... Log in to view the Equity Summary Score for CBIS Research Reports Company Research Highlights® Report (PDF) This generated report* compiles independent, third-party information highlighting key fundamental and technical data, analyst opinions, stock price movement, earnings data, and industry comparisons. Available only to Fidelity customers. S&P Compustat ® Company Report This generated report* has historical data on financials with interactive charts, technical indicators, and five-year peer comparison trend charts. *Generated reports are built dynamically when you select them. Reports may not be available for some symbols. Select the link to check availability for this symbol. CBIS Industry Comparison: Vs. Pharmaceuticals |